Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca completes divestment agreement with Atnahs Pharma for established hypertension medicines
-
AstraZeneca divests global rights to Movantik
-
Full-year and Q4 2019 results
-
Brilinta met primary endpoint in Phase III THALES trial in stroke
-
AstraZeneca divests rights to established hypertension medicines
-
Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint
-
AstraZeneca to recover the global rights to brazikumab (MEDI2070) from Allergan
-
AstraZeneca Young Health Programme to partner with UNICEF to prevent non-communicable diseases among young people
-
AstraZeneca’s ‘Ambition Zero Carbon’ strategy to eliminate emissions by 2025 and be carbon negative across the entire value chain by 2030
-
Imfinzi and tremelimumab granted Orphan Drug Designation in the US for liver cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
